| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | 17-AAG | GDSC1000 | pan-cancer | AAC | -0.057 | 0.07 |
| mRNA | Curcumin | CTRPv2 | pan-cancer | AAC | -0.06 | 0.07 |
| mRNA | tretinoin:carboplatin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.061 | 0.07 |
| mRNA | Vandetanib | CTRPv2 | pan-cancer | AAC | -0.063 | 0.07 |
| mRNA | CAY10618 | CTRPv2 | pan-cancer | AAC | 0.06 | 0.08 |
| mRNA | MLN4924 | GDSC1000 | pan-cancer | AAC | -0.068 | 0.08 |
| mRNA | Cisplatin | GDSC1000 | pan-cancer | AAC | -0.06 | 0.08 |
| mRNA | Docetaxel | GDSC1000 | pan-cancer | AAC | -0.055 | 0.08 |
| mRNA | PFI-1 | GDSC1000 | pan-cancer | AAC | -0.058 | 0.08 |
| mRNA | RDEA119 | GDSC1000 | pan-cancer | AAC | -0.053 | 0.08 |